References
- World Health Organization. WHO monitoring of Xpert MTB/RIF roll-out. 2014. Available from: http://www.who.int/tb/laboratory/mtbrifrollout/en/index.html [Accessed on 23 October 2014]
- Kik SV, Denkinger CM, Chedore P, Pai M. Replacing smear microscopy for the diagnosis of tuberculosis: what is the market potential? Eur Respir J 2014;43(6):1793-6
- Kik SV, Denkinger CM, Casenghi M, et al. Tuberculosis diagnostics: which target product profiles should be prioritised? Eur Respir J 2014;44(2):537-40
- World Health Organization. Meeting report on high-priority target product profiles for new TB diagnostics. WHO, Geneva; 2014. Available from: http://apps.who.int/iris/bitstream/10665/135617/1/WHO_HTM_TB_2014.18_eng.pdf?ua=1
- Qin ZZ, Pai M, Van Gemert W, et al. How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Eur Respir J 2014. [Epub ahead of print]
- Denkinger CM, Kik SV, Pai M. Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries. Expert Rev Mol Diagn 2013;13(8):763-7
- Foundation for Innovative New Diagnostics (FIND). Available from: www.finddiagnostics.org
- Initiative for Promoting Affordable and Quality TB Tests (IPAQT). Available from: www.ipaqt.org
- Pai M. Promoting affordable and quality tuberculosis testing in India. J Lab Physicians 2013;5(1):1-4
- UNITAID. Tuberculosis: diagnostics technology and market landscape. 3rd edition. WHO; Geneva: 2014
- TB Diagnostics Market Analysis Consortium. Market assessment of tuberculosis diagnostics in Brazil in 2012. PLoS One 2014;9(8):e104105
- TB Diagnostics Market Analysis Consortium. Market assessment of tuberculosis diagnostics in South Africa in 2012-2013. Int J Tuberc Lung Dis 2014;19(2):216-22
- Critical Path to TB Drug Regimens. Available from: www.cptrinitiative.org
- TB Alliance. Available from: www.tballiance.org